Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 33 Schemes (14.94%)
Foreign Institutions
Held by 53 Foreign Institutions (9.63%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
12 Million
(Quarterly Results - Sep 2025)
Net Profit:
-17 Million
Pharmaceuticals & Biotechnology
USD 363 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
-1.04
-999,999.00%
1.87






